ALK POSITIVE
Clinical trials for ALK POSITIVE explained in plain language.
Never miss a new study
Get alerted when new ALK POSITIVE trials appear
Sign up with your email to follow new studies for ALK POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted pill may keep ALK-Positive lung cancer from returning after surgery
Disease control OngoingThis study tests whether taking crizotinib after surgery can prevent early-stage non-small cell lung cancer from coming back in people whose tumors have a specific ALK gene change. About 166 participants who had their cancer completely removed will either take crizotinib or just …
Matched conditions: ALK POSITIVE
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control OngoingThis early-phase study tests the safety and best dose of combining two drugs, ceritinib and everolimus, in people with advanced solid tumors or a specific type of lung cancer (ALK-positive NSCLC). The goal is to find the highest dose that is safe and to see if the combination can…
Matched conditions: ALK POSITIVE
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:39 UTC